Bexicaserin
A serotonin receptor agonist
| Bexicaserin | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Bexicaserin is a chemical compound that acts as a selective agonist for the 5-HT2C receptor, a subtype of the serotonin receptor. It was developed for potential use in the treatment of various psychiatric disorders, including depression and anxiety disorders.
Pharmacology[edit]
Bexicaserin is known for its high affinity and selectivity towards the 5-HT2C receptor, which is one of the several subtypes of serotonin receptors. The activation of 5-HT2C receptors is associated with the modulation of neurotransmitter release in the brain, influencing mood, anxiety, and appetite.
Mechanism of Action[edit]
The primary mechanism of action of Bexicaserin involves the stimulation of 5-HT2C receptors, which are predominantly located in the central nervous system. Activation of these receptors can lead to increased release of dopamine and norepinephrine in certain brain regions, which are neurotransmitters involved in mood regulation and stress response.
Development and Research[edit]
Bexicaserin was initially investigated for its potential therapeutic effects in treating major depressive disorder and generalized anxiety disorder. However, despite promising preclinical results, the development of Bexicaserin was halted during clinical trials due to insufficient efficacy and concerns over side effects.
Potential Applications[edit]
Although Bexicaserin is not currently used in clinical practice, its study has contributed to the understanding of the role of 5-HT2C receptors in psychiatric conditions. Research into similar compounds continues, with the aim of developing effective treatments with fewer side effects.
Chemical Properties[edit]
Bexicaserin is a synthetic compound with the IUPAC name 1-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-3-phenylurea. It is characterized by its complex structure, which includes a piperazine ring and a phenylurea moiety.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
